Stay updated on ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.

Latest updates to the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedRevision v3.4.2 was added to the history log and Revision v3.4.1 was removed. These are site-wide updates and notices rather than changes to trial data or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.9%

- Check21 days agoChange DetectedAdded a government funding/status notice and the new site revision tag v3.4.1, and removed the previous revision tag v3.4.0.SummaryDifference0.9%

- Check28 days agoChange DetectedThe Record History page adds a glossary, color-coded highlights for additions (green) and deletions (red), and a revision badge (v3.4.0).SummaryDifference1%

- Check64 days agoChange DetectedNew revision entry Revision: v3.3.3 was added to the page history. The footer now removes HHS Vulnerability Disclosure and Revision: v3.3.2.SummaryDifference0.2%

- Check85 days agoChange DetectedThe Record History shows a new revision (v3.3.2) added and the previous revision (v3.3.1) removed, indicating a small deployment/update to the page's version history. This appears to be a non-content change related to the page’s deployment rather than to the trial information. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision history shows the addition of v3.3.1 and removal of v3.2.0, a minor platform release note that does not affect study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

Stay in the know with updates to ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ADG116 Combo With Pembrolizumab in Solid Tumors Clinical Trial page.